Medos AG

Stolberg, Germany Founded: 1978 • Age: 48 yrs Acquired By Nexus AG
Range of product and therapy solutions for cardiac surgeons and perfusionists.
Annual revenue - Latest available
Total funding - Funding intelligence
Employees - Tracked headcount
Investors 1 Known backers
Products 3 Services tracked
Competitors 10 Brand Intelligence

About Medos AG

Medos AG is a company based in Stolberg (Germany) founded in 1978 was acquired by Nexus AG in August 2008. Medos AG has completed 2 acquisitions, including Gish Biomedical and Life Systems. Medos AG offers products and services including Xenios Console, Oxygenator, and Patient Kits. Medos AG operates in a competitive market with competitors including Pulmonx, Neurent Medical, Gradient Denervation Technologies, Spiration and Uptake Medical, among others.

  • Headquarter Stolberg, Germany
  • Sectors
    Healthcare
  • Phone
    Locked
  • Website
    Locked
  • Social
    Locked
  • Legal Name Xenios Ag
Operational Areas
Healthcare → Healthcare Products & Supplies Unlock Sub-Sector Unlock Segment
Key Metrics
  • Annual Revenue
    Not available
  • Net Profit
    Not available
  • EBITDA
    Not available
  • Latest Funding Round
    Not available
  • Investors
  • Employee Count
    Not available
  • Investments & Acquisitions
  • Acquired by
    Nexus AG

    (Aug 01, 2008)

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of Medos AG

Medos AG offers a comprehensive portfolio of products and services, including Xenios Console, Oxygenator, and Patient Kits.

Product name locked
Category locked
Primary

Multifunctional platform for heart and lung support in ECMO

Product name locked
Category locked
Locked

Facilitates gas exchange for acute heart and lung failure

Product name locked
Category locked
Locked

Preconfigured sets for extracorporeal treatments

Funding Insights of Medos AG

Premium access

Detailed funding history for Medos AG

Round names, dates, amounts, investors, and valuation history require an active premium plan.

  • Round names and dates
  • Funding amounts
  • Participating investors
  • Valuation history

Verified entity values are shown only after access is granted.

Investors in Medos AG

Medos AG has secured backing from 1 investor. Prominent investors backing the company include Nexus AG.

All
Investor Description Founded Year Domain Location
End-to-end IT solutions for healthcare providers in Europe are delivered.
Locked Locked Locked
Premium access

Investor details for Medos AG

Investor domains, locations, round participation, and complete history require an active premium plan.

  • Investor domains
  • Investor locations
  • Funding rounds
  • Participation history

Verified entity values are shown only after access is granted.

Investments & Acquisitions by Medos AG

Medos AG has strategically engaged in corporate development activities, having acquired 2 companies. Notable acquisitions include Gish Biomedical and Life Systems.

Investments
Premium access

Investment portfolio details for Medos AG

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Acquisitions
Company Name Description Domain Location Founded Year Amount
Life Systems is recognized as a leader in perfusion services for cardiac surgery in Germany.
Locked Locked 1996 Locked
Manufacturer of traditional Italian gianduia chocolates and confectionery
Locked Locked 1976 Locked
Premium access

Complete acquisition details for Medos AG

Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.

  • Transaction dates
  • Acquired stakes
  • Disclosed values
  • Domains and locations

Verified entity values are shown only after access is granted.

Financial Statements - Medos AG

Premium access

Detailed financials for Medos AG

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

Medos Ag Comparisons

Medos AG Primary company
Description
Range of product and therapy solutions for cardiac surgeons ...
Location
Stolberg, Germany
Founded Year
1978
Annual Revenue
Not available
Net Profit
Not available
EBITDA
Not available
Employees
Not available
Premium access

Peer comparison for Medos AG

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of Medos AG

Medos AG operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Pulmonx, Neurent Medical, Gradient Denervation Technologies, Spiration and Uptake Medical, among others.

Company Name Domain Founded year HQ Location Description
Locked Locked Locked
Developer of smart devices for treating pulmonary diseases
Locked Locked Locked
Smart devices for minimally invasive rhinitis treatment are developed.
Locked Locked Locked
Endovascular catheter-based technology for pulmonary hypertension treatment is provided.
Locked Locked Locked
IntraBronchial Valve to treat lung disease
Locked Locked Locked
Targeted vapor therapy is developed for endoscopic lung volume reduction.
Locked Locked Locked
Endobronchial valves for emphysema treatment are developed.
Premium access

Detailed competitors of Medos AG

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Medos Ag

Premium access

Complete news archive for Medos AG

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Medos AG

Medos AG was founded in 1978.

Medos AG is headquartered in Stolberg, Germany. It is registered at Stolberg, Saxony-anhalt, Germany.

Medos is a medical device company offering a full range of product and therapy solutions for cardiac surgeons and perfusionists. The companys products include the NovaLung which is used for CO2 removal and oxygenation thereby reducing the need for mechanical ventilation and allowing minimally invasive treatment of acute and chronic lung failure, iLA Membrane Ventilator for pumpless (arterio-venous) extrapulmonary lung support, and i-Cor device which offers synchronized cardiac assist to improve myocardial and organ perfusion.The company also provides products and platforms for hemofiltration and vascular access.

Medos AG's top competitors include Pulmonx, Neurent Medical and Gradient Denervation Technologies.

Medos AG offers Xenios Console, Oxygenator, and Patient Kits.

Medos AG has made 2 acquisitions, including Gish Biomedical, and Life Systems.

Medos AG has 1 investor. Key investors include Nexus AG.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available